Observation of the effects of extracorporeal circulation on the intestinal function-related molecules in patients' blood

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2600127751

Enrollment

Unknown

Registered

2026-07-07

Start date

2026-07-10

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Superior mesenteric artery embolus

Interventions

Health examination group:None

Extracorporeal circulation group:None

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.? Age: = 18 years old; 2.? Healthy individuals or patients undergoing cardiac surgery under extracorporeal circulation (duration > 2 hours), with ASA classification of I-III; 3.? Have signed the informed consent form; 4.? Have not participated in any other clinical trials within the past 3 months.

Exclusion criteria

Exclusion criteria: 1.? History of intestinal diseases; 2.? Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Diamine oxidase;D-lactate;Intestinal fatty acid-binding protein;Lipopolysaccharide;Citrulline;Reduced glutathione;Inflammatory cytokines (TNF-a, IL-6, IL-10);	—

Countries

China

Contacts

Public ContactZhou Jun

The affiliated hospital of southwest medical university

scjunzhou@gmail.com+86 830 3165502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026